Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition

Irmgard Hofmann, Anke Baum, Marco H. Hofmann, Francesca Trapani, Claudia Reichel-Voda, Diane Ehrensperger, Martin Aichinger, Florian Ebner, Nicole Budano, Norbert Schweifer, Martina Sykora, Erik Depla, Joachim Boucneau, Andreas Gschwind, Norbert Kraut, Frank Hilberg, Klaus-Peter Künkele

Open source

DOI: 10.1124/jpet.122.001255
Published: 2023-03
Container: The Journal of Pharmacology and Experimental Therapeutics
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1124/jpet.122.001255,
  title = {Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition},
  author = {Irmgard Hofmann and Anke Baum and Marco H. Hofmann and Francesca Trapani and Claudia Reichel-Voda and Diane Ehrensperger and Martin Aichinger and Florian Ebner and Nicole Budano and Norbert Schweifer and Martina Sykora and Erik Depla and Joachim Boucneau and Andreas Gschwind and Norbert Kraut and Frank Hilberg and Klaus-Peter Künkele},
  year = {2023},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  doi = {10.1124/jpet.122.001255},
  url = {https://doi.org/10.1124/jpet.122.001255}
}

RIS

TY  - JOUR
TI  - Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
AU  - Irmgard Hofmann
AU  - Anke Baum
AU  - Marco H. Hofmann
AU  - Francesca Trapani
AU  - Claudia Reichel-Voda
AU  - Diane Ehrensperger
AU  - Martin Aichinger
AU  - Florian Ebner
AU  - Nicole Budano
AU  - Norbert Schweifer
AU  - Martina Sykora
AU  - Erik Depla
AU  - Joachim Boucneau
AU  - Andreas Gschwind
AU  - Norbert Kraut
AU  - Frank Hilberg
AU  - Klaus-Peter Künkele
PY  - 2023
JO  - The Journal of Pharmacology and Experimental Therapeutics
DO  - 10.1124/jpet.122.001255
UR  - https://doi.org/10.1124/jpet.122.001255
ER  -

APA

Hofmann, I., Baum, A., Hofmann, M. H., Trapani, F., Reichel-Voda, C., Ehrensperger, D., Aichinger, M., Ebner, F., Budano, N., Schweifer, N., Sykora, M., Depla, E., Boucneau, J., Gschwind, A., Kraut, N., Hilberg, F., & Künkele, K. (2023). Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.122.001255

Source records

crossref · retrieved 2026-09-26T19:13:26.409Z